After closing one of China's biggest-ever raises, I-Mab Biopharma nabs $104M Nasdaq IPO

After closing one of China's biggest-ever raises, I-Mab Biopharma nabs $104M Nasdaq IPO

Submitted by admin on January 17, 2020 - 12:08pm
Source: 
Fierce Biotech
News Tags: 
IPOs
China
NASDAQ
I-Mab Biopharma
autoimmune disease
cancer
Headline: 
After closing one of China's biggest-ever raises, I-Mab Biopharma nabs $104M Nasdaq IPO
snippet: 

China-based cancer and autoimmune disease biotech I-Mab Biopharma has raised $104 million on the U.S. Nasdaq composite.

Do Not Allow Advertisers to Use My Personal information